Invention Publication
- Patent Title: THIOACRYLAMIDE DERIVATIVES FOR USE IN THE PREVENTION OR TREATMENT OF LIVER FIBROSIS
-
Application No.: EP22210143.8Application Date: 2022-11-29
-
Publication No.: EP4378459A1Publication Date: 2024-06-05
- Inventor: Niersmann, Corinna , Rohbeck, Elisabeth , Roden, Michael , Eckel, Jürgen
- Applicant: CMR CureDiab Metabolic Research GmbH , Deutsches Diabetes-Zentrum (DDZ) Leibniz-Zentrum für Diabetes-Forschung an der Heinrich-Heine- Universität Düsseldorf
- Applicant Address: DE 40225 Düsseldorf Merowingerplatz 1
- Assignee: CMR CureDiab Metabolic Research GmbH,Deutsches Diabetes-Zentrum (DDZ) Leibniz-Zentrum für Diabetes-Forschung an der Heinrich-Heine- Universität Düsseldorf
- Current Assignee: CMR CureDiab Metabolic Research GmbH,Deutsches Diabetes-Zentrum (DDZ) Leibniz-Zentrum für Diabetes-Forschung an der Heinrich-Heine- Universität Düsseldorf
- Current Assignee Address: DE 40225 Düsseldorf Merowingerplatz 1
- Agency: Eisenführ Speiser
- Main IPC: A61K31/275
- IPC: A61K31/275 ; A61P1/16
Abstract:
The present invention relates to a thioacrylamide derivative for use in the prevention or treatment of liver fibrosis in a subject or to a pharmaceutical composition comprising such a thioacrylamide derivative for use in the prevention or treatment of liver fibrosis in a subject. Furthermore, the present invention relates to a pharmaceutical composition comprising one or more thioacrylamide derivatives.
Information query
